Stereotactic radiosurgery in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma

被引:0
|
作者
Long, H. [1 ]
机构
[1] Southern Med Univ, Dept Neurosurg, Nanfang Hosp, Affiliated South Hosp, Guangzhou, Guangdong, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
122P
引用
收藏
页码:36 / 36
页数:1
相关论文
共 50 条
  • [21] Ibrutinib in Combination with Rituximab and High-Dose Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma Patients
    Guo, Yixian
    Lan, Xiaoxi
    Chang, Xiaoli
    Wang, Guoxiang
    Zou, Dongmei
    Su, Li
    Sun, Wanling
    [J]. BLOOD, 2021, 138
  • [22] Management of Patients With Primary Central Nervous System Lymphoma Treated With High-Dose Methotrexate
    Warnick, Elizabeth
    Auger, Danielle
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (02) : 177 - 180
  • [23] A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
    Villanueva, Gabriela
    Guscott, Martin
    Schaiquevich, Paula
    Sampor, Claudia
    Combs, Ryan
    Tentoni, Nicolas
    Hwang, Miriam
    Lowe, Jennifer
    Howard, Scott
    [J]. CANCERS, 2023, 15 (05)
  • [24] Outcome after high-dose methotrexate and radiotherapy for primary central nervous system lymphoma
    Choi, J. H.
    Kim, I. H.
    Heo, D. S.
    Jung, H. W.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 501 - 501
  • [25] Population Pharmacokinetics of High-Dose Methotrexate in Patients With Primary Central Nervous System Lymphoma
    Mei, Shenghui
    Li, Xingang
    Jiang, Xueyun
    Yu, Kefu
    Lin, Song
    Zhao, Zhigang
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (05) : 1454 - 1460
  • [26] Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma
    Hanna, Colette
    Villa, Diego
    Irani, Carla
    Ghosn, Marwan
    El Rassy, Elie
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05): : E197 - E200
  • [27] High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
    Jahnke, K
    Korfel, A
    Martus, P
    Weller, M
    Herrlinger, U
    Schmittel, A
    Fischer, L
    Thiel, E
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (03) : 445 - 449
  • [28] Outcome after High-dose Methotrexate and Radiotherapy in Primary Central Nervous System Lymphoma
    Choi, J.
    Kim, I.
    Heo, D.
    Jung, H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S254 - S254
  • [29] High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma
    Freeman, Tracelyn
    Legasto, Carlo S.
    Schickli, M. Alexandra
    McLaughlin, Eric M.
    Giglio, Pierre
    Puduvalli, Vinay
    Gonzalez, Javier
    [J]. NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [30] High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
    Masaki, Yasufumi
    Miki, Miyuki
    Sun, Yue
    Nakamura, Takuji
    Iwao, Haruka
    Nakajima, Akio
    Kurose, Nozomu
    Sakai, Tomoyuki
    Jin, Zhe-Xiong
    Sawaki, Toshioki
    Kawanami, Takafumi
    Fujita, Yoshimasa
    Tanaka, Masao
    Fukushima, Toshihiro
    Hirose, Yuko
    Umehara, Hisanori
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (06) : 720 - 726